相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nobiletin exhibits potent inhibition on tumor necrosis factor alpha-induced calcification of human aortic valve interstitial cells via targeting ABCG2 and AKR1B1
Kang Xu et al.
PHYTOTHERAPY RESEARCH (2019)
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
Annemarie Schwab et al.
CANCER RESEARCH (2018)
REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer
Qingwei Wang et al.
CLINICAL CANCER RESEARCH (2018)
How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases
Wenyi Zhou et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Activation of human aortic valve interstitial cells by local stiffness involves YAP-dependent transcriptional signaling
Rosaria Santoro et al.
BIOMATERIALS (2018)
The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration
Jun Wang et al.
NATURE REVIEWS CARDIOLOGY (2018)
Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hall-marks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells
Kranthi K. K. Tanagala et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro
Srinivasan Senthilkumari et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
NADPH Oxidase Deficiency: A Multisystem Approach
Giuliana Giardino et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves
Rui Song et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
Arkady Rutkovskiy et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?
J. Ballekova et al.
PHYSIOLOGICAL RESEARCH (2017)
Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers
K. Ashok Reddy et al.
BREAST (2017)
The modern epidemiology of heart valve disease
Sean Coffey et al.
HEART (2016)
Endothelial-mesenchymal transition in atherosclerotic lesion calcification
Kristina I. Bostroem et al.
ATHEROSCLEROSIS (2016)
A Role for Partial Endothelial-Mesenchymal Transitions in Angiogenesis?
Katrina M. Welch-Reardon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Calcific Aortic Valve Disease A Consensus Summary From the Alliance of Investigators on Calcific Aortic Valve Disease
Katherine E. Yutzey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells
Wenjun Yu et al.
CELLULAR SIGNALLING (2014)
Deletion of Yes-Associated Protein ( YAP) Specifically in Cardiac and Vascular Smooth Muscle Cells Reveals a Crucial Role for YAP in Mouse Cardiovascular Development
Yong Wang et al.
CIRCULATION RESEARCH (2014)
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders
Satish K. Srivastava et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
Kristina I. Bostroem et al.
CIRCULATION RESEARCH (2011)
Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms
Jordan D. Miller et al.
CIRCULATION RESEARCH (2011)
Drug discovery and development focusing on existing medicines: drug re-profiling strategy
Tohru Mizushima
JOURNAL OF BIOCHEMISTRY (2011)
Animal Models of Calcific Aortic Valve Disease
Krista L. Sider et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Structural insights into the YAP and TEAD complex
Ze Li et al.
GENES & DEVELOPMENT (2010)
Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions
Angel Catala
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
Oxidative stress as a mediator of cardiovascular disease
Maqsood M. Elahi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Examination of Questionnaire Items regarding Diabetic Peripheral Neuropathy in Epalrestat-treated Patients and Their Usefulness in the Treatment of This Disorder - Influence on Treatment Course
Atsuo Ito et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2009)
Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis
Christian A. Gleissner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification
Marcel Liberman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling
Chang Hyun Byon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans
Jordan D. Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Epalrestat: An aldose reductase inhibitor for the treatment of diabetic neuropathy
Mary Ann Ramirez et al.
PHARMACOTHERAPY (2008)
The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology
Amber C. Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Regulation of lens aldose reductase activity by nitric oxide
S Srivastava et al.
EXPERIMENTAL EYE RESEARCH (2005)
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
RK Vikramadithyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
All in the family: aldose reductase and closely related aldo-keto reductases
JM Petrash
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
A prospective survey of patients with valvular heart disease in Europe:: The Euro Heart Survey on Valvular Heart Disease
B Iung et al.
EUROPEAN HEART JOURNAL (2003)
Bone formation and inflammation in cardiac valves
ER Mohler et al.
CIRCULATION (2001)
Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase
S Srivastava et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
分享论文
